Search results
FibroGen To Begin Trials on Tumor Treatment After FDA OK
Morningstar· 13 hours agoFibroGen can begin conducting clinical trials for its potential solid tumor treatment after regulators approved the company's application. The San Francisco-based company ...
FibroGen Stock Is Surging After The Bell: What's Going On? - FibroGen (NASDAQ:FGEN)
Benzinga· 12 hours agoThe company also announced a new clinical trial supply agreement with Regeneron. What Happened:...
Hansa completes randomisation in Phase III trial of imlifidase
Clinical Trials Arena via Yahoo Finance· 1 day agoHansa Biopharma is committed to further substantiating the clinical evidence of imlifidase through...
Walgreens will conduct clinical trials for Boehringer Ingelheim's new obesity drug
BenefitsPRO· 18 hours agoThe drugmaker is moving into Phase III studies for survodutide, which it is developing in...
FDA selects Denali's DNL126 for rare disease program By Investing.com
Investing.com· 15 hours agoThe program aims to expedite the development of treatments for rare diseases by enhancing...
Promising trial data for Moderna's skin cancer vaccine sends stock rising
Quartz· 14 hours agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 6 days agoThis decision comes after recent consultations with the U.S. Food and Drug Administration (FDA) and...
Structure Posts Positive Topline Results From GSBR-1290 Trials In Obesity; Stock Up In Pre-market
RTT News· 21 hours agoStructure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company focused on metabolic and cardiopulmonary diseases, announced Monday positive 12-week ...
The FDA may approve psychedelics for treating PTSD. Here's what to know
Quartz· 1 day agoThe public benefit company Lykos Therapeutics submitted a new drug application late last year to the...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe results from the open-label Phase Ib/II study (NCT04305795) will...at the upcoming American...